Moneycontrol PRO
Live Now |Nifty Banker 2.0 - India's First Retail Index Traders Online Conference brought to you by Moneycontrol Pro & Espresso.
you are here: HomeNewscoronavirus

Big Story | Serum Institute to seek Rs 100 crore In damages from vaccine volunteer: A look at Covishield legal row

The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.

November 30, 2020 / 05:38 PM IST
As questions mounted on Oxford-AstraZeneca vaccine trials in India after a 40-year-old participant fell sick and sought damages of Rs 5 crore, Serum Institute of India responded to allegations by preparing a Rs 100 crore defamation suit against him.
Moneycontrol News
first published: Nov 30, 2020 05:37 pm
Sections
ISO 27001 - BSI Assurance Mark